Literature DB >> 17184718

Treatment of rhegmatogenous retinal detachment in teenagers by pneumatic retinopexy technique.

San-Ni Chen1, Jiunn-Feng Hwang.   

Abstract

PURPOSE: To evaluate the effectiveness of pneumatic retinopexy as an alternative technique for rhegmatogenous retinal detachment (RD) repair in teenagers.
DESIGN: Retrospective, noncomparative, interventional case series.
METHODS: We conducted a review of 19 patients (19 eyes) younger than 20 years of age who had undergone pneumatic retinopexy as the initial procedure for rhegmatogenous RD between 1995 and 2002.
RESULTS: Fourteen boys and five girls (mean age of 17.1 years) were included in this study. Two eyes had a history of trauma. Seventeen eyes (89.5%) had myopia of > -3 diopters. The averaged refraction of the operated eyes was -6.11 diopters (range, -1.25 to -9.5 diopters). Macular detachment was found in 13 eyes (68.4%). Subretinal fibrosis was present in six eyes (31.6%). Pneumatic retinopexy resulted in reattachment in 16 eyes (84.2%) with one injection of gas. One patient required a second injection of gas. Two patients needed additional scleral buckling to attach the retina. Displaced subretinal fluid and delayed resorption of subretinal fluid were noted in four eyes. Mean follow-up period was 42.7 months (range, six to 75 months).
CONCLUSIONS: Rhegmatogenous RD in teenagers can be treated with pneumatic retinopexy with an overall successful rate as in adults. More attention is required regarding the postoperative stage and follow-up period to ensure surgical success.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17184718     DOI: 10.1016/j.ajo.2006.10.037

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  2 in total

1.  Cataract formation following vitreoretinal procedures.

Authors:  Hao Feng; Ron A Adelman
Journal:  Clin Ophthalmol       Date:  2014-09-23

Review 2.  Pneumatic retinopexy: patient selection and specific factors.

Authors:  Stephen Stewart; Wing Chan
Journal:  Clin Ophthalmol       Date:  2018-03-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.